{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:15:40Z","timestamp":1790957740728,"version":"4.1.0"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":4750,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[1996,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    The purpose of this double\u2010blind, placebo\u2010controlled study was to evaluate the clinical efficacy and tolerability of topical\n                    <jats:italic>Aloe vera<\/jats:italic>\n                    extract 0.5% in a hydrophilic cream to cure patients with psoriasis vulgaris. Sixty patients (36M\/24F) aged 18\u201350 years (mean 25.6) with slight to moderate chronic plaque\u2010type psoriasis and PASI (Psoriasis Area and Severity Index) scores between 4.8 and 16.7 (mean 9.3) were enrolled and randomized to two parallel groups. The mean duration of the disease prior to enrolment was 8.5 years (range 1\u201321). Patients were provided with a precoded 100 g tube, placebo or active (with 0.5%\n                    <jats:italic>Aloe vera<\/jats:italic>\n                    extract), and they self\u2010administered trial medication topically (without occlusion) at home 3 times daily for 5 consecutive days per week (maximum 4 weeks active treatment). Patients were examined on a weekly basis and those showing a progressive reduction of lesions, desquamation followed by decreased erythema, infiltration and lowered PASI score were considered healed. The study was scheduled for 16 weeks with 12 months of follow\u2010up on a monthly basis. The treatment was well tolerated by all the patients, with no adverse drug\u2010related symptoms and no dropouts. By the end of the study, the\n                    <jats:italic>Aloe vera<\/jats:italic>\n                    extract cream had cured 25\/30 patients (83.3%) compared to the placebo cure rate of 2\/30 (6.6%) (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001) resulting in significant clearing of the psoriatic plaques (328\/396 (82.8%)\n                    <jats:italic>vs<\/jats:italic>\n                    placebo 28\/366 (7.7%),\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001) and a decreased PASI score to a mean of 2.2. The findings of this study suggest that topically applied\n                    <jats:italic>Aloe vera<\/jats:italic>\n                    extract 0.5% in a hydrophilic cream is more effective than placebo, and has not shown toxic or any other objective side\u2010effects. Therefore, the regimen can be considered a safe and alternative treatment to cure patients suffering from psoriasis.\n                  <\/jats:p>","DOI":"10.1046\/j.1365-3156.1996.d01-91.x","type":"journal-article","created":{"date-parts":[[2003,11,3]],"date-time":"2003-11-03T16:02:14Z","timestamp":1067875334000},"page":"505-509","source":"Crossref","is-referenced-by-count":159,"title":["Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo\u2010controlled, double\u2010blind study*"],"prefix":"10.1111","volume":"1","author":[{"given":"Tanweer A.","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ashfaq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert H.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hamzeh","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.7547\/87507315-81-9-473"},{"key":"e_1_2_1_3_1","first-page":"31","volume-title":"CRC Handbook of Medicinal Herbs","author":"Duke JA","year":"1985"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.131.7.791"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"e_1_2_1_6_1","unstructured":"KentCM(1979)Aloe vera Arlington VA p.66."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70095-X"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.131.7.842"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/archderm.1989.01670240047011","article-title":"Treatment of psoriasis by topical application of the novel cholecalciferol analogue calcipotriol (MC 903)","volume":"125","author":"Kragballe K.","year":"1989","journal-title":"Archives of Dermatology"},{"key":"e_1_2_1_10_1","first-page":"542","article-title":"Topical therapy for psoriasis","volume":"34","author":"Lebwohl M.","year":"1995","journal-title":"International Journal of Dermatology"},{"key":"e_1_2_1_11_1","first-page":"S169","article-title":"Topical calcipotriol (MC 903) for psoriasis: a clinical study","volume":"186","author":"Mozzanica N.","year":"1994","journal-title":"Acta Dermato-Venereologica"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archderm.1995.01690200101025","article-title":"Pilot study of topical calcitriol (1, 25\u2010dihydroxyvitamin D3) for treating psoriasis in children","volume":"131","author":"Perez A.","year":"1995","journal-title":"Archives of Dermatology"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb02607.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70207-8"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246530"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00198242","article-title":"Human leukocyte interferon\u2010\u03b1 in cream for the management of genital herpes in Asian women. A placebo\u2010controlled, double\u2010blind study","volume":"73","author":"Syed TA","year":"1995","journal-title":"Journal of Molecular Medicine"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.1996.d01-91.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.1996.d01-91.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T01:40:15Z","timestamp":1698370815000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.1996.d01-91.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["10.1046\/j.1365-3156.1996.d01-91.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.1996.d01-91.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}